CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 10 enrolled
Drug / intervention
C1 Implantdrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01746160
NCT01746160N/ACompleted
CompareCT.gov

A Short-term Longitudinal Follow-up After C1 Implant Stability Values.

Hadassah Medical Organization·interventional·Posted Dec 10, 2012·Updated Aug 5, 2022

In Brief

A clinical study evaluating C1 Implant for Jaw, Edentulous, Partially. Completed, enrolled 10 participants across 1 site.

Detailed Summary

The aim of the study is to describe the changes found in C1 dental implants through their early healing period. Patients requiring a standard installation of one or two implants in the maxilla, without any need for bone augmentation, will be frequently followed for 90 days. In every meeting the implants' ISQ values (values denoting the implant stability as being measured by a dedicated, commercially available, appliance called 'Osstell'). The implants' measured ISQ values will be used to describe the changes that may be found in the implants' stability through their healing period. At the end of the study the patients will be referred to their treating doctor for the completion of implants' restoration (i.e. crown).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsJaw, Edentulous, Partially
CountriesIsrael
Collaborators--

Timeline

N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedDec 10, 2012
Enrollment StartDec 1, 2012
Primary CompletionFeb 1, 2018
TodayJul 2, 2026
Enrollment to primary: 5.2 yearsPosted 13.6 years ago

Interventions

C1 Implantdrug

Patients treated with dental implants.